Feldan Therapeutics
PrivateLast Round
Grant
Mar 12, 2026
Total Funding Raised
$52.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Feldan Therapeutics is a biopharmaceutical company specializing in the development of innovative treatments through advanced intracellular delivery technologies that enhance the safe and efficient transport of therapeutic compounds into cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Feldan Therapeutics Comparables
Compare Feldan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Permeasis Therapeutics | 85% | |
| iDEL Therapeutics | 79% | |
| NanoSyrinx | 78% | |
Feldan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 12, 2026 | ||||
| Grant | Sep 23, 2025 | ||||
| Series B | Apr 16, 2025 | ||||
| Strategic | Feb 18, 2025 | ||||
| Series B Extension | Sep 4, 2024 | ||||
Grant | Aug 28, 2023 |
Key People
Founding team and executive leadership
Feldan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Investissement Québec | Series B Extension, Series B |
| Investissement Québec | Series B, Strategic, Series B Extension |
| Fonds de solidarité FTQ | Strategic, Series B Extension |
| Consortium Québécois sur la découverte du médicament | Grant |
| Future Standard | Series B |
| Zynext Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 45% MoM.
- Mar 12, 2026
$330K grant from Canadian government agencies.
Feldan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Feldan Therapeutics's valuation, stock price, and market status.